全球醫藥中間體市場-市場規模、份額和增長分析：按產品（化學中間體、API中間體）、按應用（鎮痛藥、抗炎藥）-行業預測（2023-2030）

2021年全球醫藥中間體市場規模將達到290億美元，2022年將達到306億美元。 預計該市場在預測期內（2023-2030年）將以復合年增長率6.3%的速度擴張，並於2030年擴大至526億美元。

醫藥中間體作為原料藥的生產原料發揮著重要作用。 這些中間體是在進一步加工之前的活性藥物成分 (API) 合成過程中形成的。 這些中間體均採用優質基礎原料製成，廣泛應用於醫藥和化妝品行業。 由於這些領域的需求不斷增長，特別是用於研發目的，全球醫藥中間體市場正在經歷增長。

慢性病患病率的上升和世界人口的老齡化是導致對治療這些疾病的藥物製劑的需求增加的重要因素。 根據世界衛生組織（WHO）的數據，糖尿病患者人數從1980年的1.08億增加到2014年的4.22億，並且這一趨勢仍在持續。 此外，世界衛生組織預測，到 2020 年，慢性病的發病率將增加 57%，這意味著很大一部分人口受到這些疾病的影響。 因此，由於這些驅動因素，醫藥市場在預測期內呈現增長。

全球醫藥中間體市場面臨兩個關鍵因素驅動的增長挑戰。 首先，獲得生物藥品的高成本是一個主要障礙。 其次，生產活性藥物成分（API）所需的高資本投資是限制市場增長的重要因素。

本報告考察了全球醫藥中間體市場，並按產品、應用、地區和進入市場的公司概況提供了市場概述以及趨勢。

內容

執行摘要

調查方法

母公司市場分析

• 市場概況
• 市場規模
• 市場動態

主要市場洞察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 知識產權分析
• 貿易分析
• 啟動分析
• 原材料分析
• 創新矩陣
• 管道產品分析
• 宏觀經濟指標
• 熱門投資分析
• 關鍵成功因素
• 爭用程度

市場動態與展望

• 市場動態
  • 驅動程序
  • 機會
  • 制約因素
  • 任務
• 監管狀況
• 波特分析

全球醫藥中間體市場，按產品

• 市場概況
• 化學中間體
• API中間體
• 和定制中間體

全球醫藥中間體市場，按應用劃分

• 市場概況
• 止痛藥
• 抗炎藥
• 心血管藥物
• 抗糖尿病藥物
• 抗癌劑

全球醫藥中間體市場規模（按地區）

• 市場概況
• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲

競爭格局

主要公司簡介

• BASF SE
• Lonza Group AG
• Thermo Fisher Scientific Inc.
• Wuxi AppTec Co. Ltd.
• Merck KGaA
• Dishman Group
• Codexis Inc.
• Cambrex Corporation
• Hikal Ltd.
• Chemcon Speciality Chemicals Ltd.
• Porton Fine Chemicals Ltd.
• Divis Laboratories Ltd.
• Pfizer CentreOne
• Aurobindo Pharma Ltd.
• Sanofi SA
• Lianhe Chemical Technology Co. Ltd.
• Jiangsu Hengrui Medicine Co. Ltd.
• Shandong Xinhua Pharmaceutical Co. Ltd.
• WuXi STA
• Zhejiang NHU Co. Ltd.

Global Pharmaceutical Intermediates Market size was valued at USD 29 billion in 2021 and is poised to grow from USD 30.6 billion in 2022 to USD 52.6 billion by 2030, growing at a CAGR of 6.3% in the forecast period (2023-2030).

Pharmaceutical intermediates play a crucial role as raw materials in the production of bulk drugs. These intermediates are formed during the synthesis of active pharmaceutical ingredients (APIs) before further processing. They are derived from high-quality basic ingredients and find extensive applications in the pharmaceutical and cosmetic industries. The global market for pharmaceutical intermediates is experiencing growth due to the rising demand in these sectors, particularly for research and development purposes.

These intermediates are essential in the manufacturing of various products, including pesticides, drugs, resins, additives, plasticizers, and more, using materials like coal tar or petroleum. The market's expansion is primarily driven by the increased production of active pharmaceutical ingredients, responding to the growing demand for advanced therapies with improved delivery systems and personalized medicines worldwide.

Despite the positive outlook, the industry faces challenges such as the high cost of acquiring biopharmaceutical drugs and substantial apital investments required for API production. However, the introduction of new technologies in pharmaceutical manufacturing and increased investment in research activities are expected to create promising growth opportunities in the coming years.

Segments covered in this report:

Global pharmaceutical intermediates market is segmented on the basis of product, application, and region. On the basis of product, global market is segmented into chemical intermediates, bulk drug intermediates and custom intermediates. On the basis of application, global market is segmented into, analgesics, anti-inflammatory drug, cardiovascular drugs, anti-diabetic drugs and anti-cancer drugs. On the basis of region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

The rising prevalence of chronic diseases and the global aging population are significant factors contributing to an increased demand for drug formulations to manage these conditions. According to the World Health Organization (WHO), the cases of diabetes have escalated from 108.0 million in 1980 to 422.0 million in 2014, with a continuous upward trend. Additionally, the WHO predicts a 57% increase in the incidence of chronic diseases by 2020, signifying a substantial portion of the population being affected by these conditions. As a result, the pharmaceutical market is witnessing growth during the forecast period due to these driving factors.

Restraint

The global pharmaceutical intermediates market faces challenges to its growth due to two significant factors. Firstly, the high expenses associated with acquiring biopharmaceutical drugs act as a major hindrance. Secondly, the substantial capital investment required for the production of active pharmaceutical ingredients (APIs) serves as a significant restraint that could impede the market's growth.

Market Trends

The cost incurred by the nation's healthcare system due to heart disease is on the rise. An important trend observed in the pharmaceutical intermediates market is the increasing prevalence of chronic cardiovascular conditions like heart failure and coronary artery disease. A July 2020 paper published in the Curious Journal of Medical Science states that ischemic heart disease (IHD) ranks as the leading cause of death worldwide. Approximately 126 million people globally are affected by ischemic heart disease. The projections indicate that by 2030, there will be over 1,845 cases of ischemic heart disease per 100,000 individuals worldwide.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Pharmaceutical Intermediates Market by Product

• Market Overview
• Chemical intermediates
• Bulk drug intermediates
• and Custom intermediates

Global Pharmaceutical Intermediates Market by Application

• Market Overview
• Analgesics
• Anti-inflammatory drug
• Cardiovascular drugs
• Anti-diabetic drugs
• Anti-cancer drugs

Global Pharmaceutical Intermediates Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dishman Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codexis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikal Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemcon Speciality Chemicals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Porton Fine Chemicals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Divis Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer CentreOne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lianhe Chemical Technology Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Hengrui Medicine Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Xinhua Pharmaceutical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi STA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang NHU Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments